Back to news

Canon Medical and Stereotaxis Collaborate to Advance Robotic Electrophysiology

Globe Newswire•30/10/2026•08:03 ET
1

Key Highlights

  • ➤Canon Alphenix and Stereotaxis GenesisX to be offered in compatible fashion
  • ➤Collaboration aims to expand access to robotic electrophysiology technology
  • ➤Companies will explore workflow improvements and advanced electrophysiology capabilities
  • ➤Technologies to be presented at TCT 2026 in Canon’s booth

Expert Statements

Tsuneo “Neo” Imai, President & CEO of Canon Medical Systems USA

“As electrophysiology continues to evolve, customers need the flexibility to build advanced labs around the technologies and workflows that best meet their needs.”

Tsuneo “Neo” Imai, President & CEO of Canon Medical Systems USA

“Our collaboration with Stereotaxis reinforces Canon Medical's commitment to customer choice and creates an exciting opportunity to bring Alphenix imaging together with Robotic Magnetic Navigation.”

David Fischel, Chairman and CEO of Stereotaxis

“We are delighted to collaborate with Canon Medical to bring together two complementary technologies for the modern EP lab.”

David Fischel, Chairman and CEO of Stereotaxis

“More tightly coordinating the delivery of advanced interventional imaging and robotic technologies offers hospitals an exciting approach to building their robotic electrophysiology programs.”

* Collaboration brings together Canon’s Alphenix interventional fluoroscopy system and Stereotaxis’ GenesisX robotic technology * Technologies will be presented at TCT 2026 in the Canon booth TUSTIN, Calif. and ST. LOUIS, Oct. 30, 2026 (GLOBE NEWSWIRE) -- Canon Medical Systems USA, a leader in innovative diagnostic imaging solutions, and Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced a technology compatibility and commercial collaboration to pair Canon Medical’s Alphenix interventional imaging platform with Stereotaxis’ GenesisX Robotic Magnetic Navigation system.

Canon and Stereotaxis are collaborating to offer their respective systems in a compatible fashion alongside each other. Canon Medical's Alphenix platform provides advanced imaging, visualization, dose-management and workflow capabilities for interventional cardiology, with flexible configurations designed to support complex procedures. GenesisX enables precise robotic navigation of interventional catheters, with a semi-mobile architecture designed to facilitate adoption broadly within existing catheterization labs without any construction.

Get started

Create a free account to read the full story.

Sign Up

Already have an account? Log in